Literature DB >> 29156205

Which factors influence the development of GVHD in HLA-matched or mismatched transplants?

Effie W Petersdorf1.   

Abstract

The sheer diversity of HLA alleles makes the probability of finding matched unrelated donors for patients requiring hematopoietic cell transplantation (HCT) a complex situation. New evidence suggests that mismatching at certain HLA loci may provide a greater benefit in terms of graft-versus-leukemia effect than other mismatches when HLA-matched donors are not available. This review summarizes the current understanding of HLA matching requirements for unrelated donor HCT.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Allele; GVHD; GVL; Graft versus leukemia; Graft-versus-host disease; HCT; HLA; Hematopoietic cell transplantation; Matched; Mismatched

Mesh：

Substances：

Year:  2017        PMID： 29156205      PMCID： PMC5967625          DOI： 10.1016/j.beha.2017.09.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN： 1521-6926            Impact factor:   3.020


  14 in total

1.  Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis.

Authors:  Mary Eapen; John P Klein; Guillermo F Sanz; Stephen Spellman; Annalisa Ruggeri; Claudio Anasetti; Maria Brown; Richard E Champlin; Joan Garcia-Lopez; Gareth Hattersely; Gesine Koegler; Mary J Laughlin; Gerard Michel; Samir K Nabhan; Franklin O Smith; Mary M Horowitz; Eliane Gluckman; Vanderson Rocha
Journal:  Lancet Oncol       Date:  2011-10-06       Impact factor: 41.316

2.  MHC Class I Chain-Related Gene A (MICA) Donor-Recipient Mismatches and MICA-129 Polymorphism in Unrelated Donor Hematopoietic Cell Transplantations Has No Impact on Outcomes in Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome: A Center for International Blood and Marrow Transplant Research Study.

Authors:  Medhat Askar; Ronald Sobecks; Tao Wang; Mike Haagenson; Navneet Majhail; Abeer Madbouly; Dawn Thomas; Aiwen Zhang; Katharina Fleischhauer; Katharine Hsu; Michael Verneris; Stephanie J Lee; Stephen R Spellman; Marcelo Fernández-Viña
Journal:  Biol Blood Marrow Transplant       Date:  2016-12-14       Impact factor: 5.742

3.  Matching for the MICA-129 polymorphism is beneficial in unrelated hematopoietic stem cell transplantation.

Authors:  Daniel Fuerst; Christine Neuchel; Dietger Niederwieser; Donald Bunjes; Martin Gramatzki; Eva Wagner; Gerald Wulf; Bertram Glass; Michael Pfreundschuh; Hermann Einsele; Renate Arnold; Gernot Stuhler; Kerstin Schaefer-Eckart; Sebastian Freitag; Jochen Casper; Martin Kaufmann; Mohammed Wattad; Bernd Hertenstein; Stefan Klein; Mark Ringhoffer; Daphne Mytilineos; Chrysanthi Tsamadou; Carlheinz Mueller; Hubert Schrezenmeier; Joannis Mytilineos
Journal:  Blood       Date:  2016-11-03       Impact factor: 22.113

4.  Biological significance of HLA locus matching in unrelated donor bone marrow transplantation.

Authors:  Yasuo Morishima; Koichi Kashiwase; Keitaro Matsuo; Fumihiro Azuma; Satoko Morishima; Makoto Onizuka; Toshio Yabe; Makoto Murata; Noriko Doki; Tetsuya Eto; Takehiko Mori; Koichi Miyamura; Hiroshi Sao; Tatsuo Ichinohe; Hiroo Saji; Shunichi Kato; Yoshiko Atsuta; Keisei Kawa; Yoshihisa Kodera; Takehiko Sasazuki
Journal:  Blood       Date:  2014-12-17       Impact factor: 22.113

5.  HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.

Authors:  Effie W Petersdorf; Theodore A Gooley; Mari Malkki; Andrea P Bacigalupo; Anne Cesbron; Ernette Du Toit; Gerhard Ehninger; Torstein Egeland; Gottfried F Fischer; Thibaut Gervais; Michael D Haagenson; Mary M Horowitz; Katharine Hsu; Pavel Jindra; Alejandro Madrigal; Machteld Oudshoorn; Olle Ringdén; Marlis L Schroeder; Stephen R Spellman; Jean-Marie Tiercy; Andrea Velardi; Campbell S Witt; Colm O'Huigin; Richard Apps; Mary Carrington
Journal:  Blood       Date:  2014-10-16       Impact factor: 22.113

6.  Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation.

Authors:  Marcelo A Fernández-Viña; John P Klein; Michael Haagenson; Stephen R Spellman; Claudio Anasetti; Harriet Noreen; Lee Ann Baxter-Lowe; Pedro Cano; Neal Flomenberg; Dennis L Confer; Mary M Horowitz; Machteld Oudshoorn; Effie W Petersdorf; Michelle Setterholm; Richard Champlin; Stephanie J Lee; Marcos de Lima
Journal:  Blood       Date:  2013-04-17       Impact factor: 22.113

7.  Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome.

Authors:  Yvette L Kasamon; Leo Luznik; Mary S Leffell; Jeanne Kowalski; Hua-Ling Tsai; Javier Bolaños-Meade; Lawrence E Morris; Pamela A Crilley; Paul V O'Donnell; Nancy Rossiter; Carol Ann Huff; Robert A Brodsky; William H Matsui; Lode J Swinnen; Ivan Borrello; Jonathan D Powell; Richard F Ambinder; Richard J Jones; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2010-01-18       Impact factor: 5.742

8.  HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.

Authors:  Loren Gragert; Mary Eapen; Eric Williams; John Freeman; Stephen Spellman; Robert Baitty; Robert Hartzman; J Douglas Rizzo; Mary Horowitz; Dennis Confer; Martin Maiers
Journal:  N Engl J Med       Date:  2014-07-24       Impact factor: 91.245

9.  The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy.

Authors:  Craig Kollman; Stephen R Spellman; Mei-Jie Zhang; Anna Hassebroek; Claudio Anasetti; Joseph H Antin; Richard E Champlin; Dennis L Confer; John F DiPersio; Marcelo Fernandez-Viña; Robert J Hartzman; Mary M Horowitz; Carolyn K Hurley; Chatchada Karanes; Martin Maiers; Carlheinz R Mueller; Miguel-Angel Perales; Michelle Setterholm; Ann E Woolfrey; Neng Yu; Mary Eapen
Journal:  Blood       Date:  2015-11-02       Impact factor: 22.113

10.  8/8 and 10/10 high-resolution match rate for the be the match unrelated donor registry.

Authors:  Jason Dehn; Kelly Buck; Martin Maiers; Dennis Confer; Robert Hartzman; Craig Kollman; Alexander H Schmidt; Soo Young Yang; Michelle Setterholm
Journal:  Biol Blood Marrow Transplant       Date:  2014-10-13       Impact factor: 5.742
View more
  4 in total

1.  Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen-mismatched donors.

Authors:  Brian Kornblit; Barry E Storer; Niels S Andersen; Michael B Maris; Thomas R Chauncey; Effie W Petersdorf; Ann E Woolfrey; Mary E D Flowers; Rainer Storb; David G Maloney; Brenda M Sandmaier
Journal:  Blood       Date:  2020-09-24       Impact factor: 22.113

2.  High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation.

Authors:  Stéphane Buhler; Helen Baldomero; Sylvie Ferrari-Lacraz; José Manuel Nunes; Alicia Sanchez-Mazas; Stravroula Massouridi-Levrat; Dominik Heim; Jörg Halter; Gayathri Nair; Yves Chalandon; Urs Schanz; Tayfun Güngör; Grazia Nicoloso; Jean-Marie Tiercy; Jakob Passweg; Jean Villard
Journal:  Bone Marrow Transplant       Date:  2019-04-05       Impact factor: 5.483

Review 3.  Role of Polymorphisms of NKG2D Receptor and Its Ligands in Acute Myeloid Leukemia and Human Stem Cell Transplantation.

Authors:  Alena Machuldova; Monika Holubova; Valentina S Caputo; Miroslava Cedikova; Pavel Jindra; Lucie Houdova; Pavel Pitule
Journal:  Front Immunol       Date:  2021-03-30       Impact factor: 7.561

4.  HLA-SPREAD: a natural language processing based resource for curating HLA association from PubMed abstracts.

Authors:  Dhwani Dholakia; Ankit Kalra; Bishnu Raman Misir; Uma Kanga; Mitali Mukerji
Journal:  BMC Genomics       Date:  2022-01-07       Impact factor: 3.969
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.